Dr. Hajra I. Tily, MD

Dr. Tily practices at Sutter Valley Medical Foundation in Modesto, California.

Dr. Tily's NPI, 1629246228, was assigned on February 15, 2008. Dr. Tily graduated from Dow University of Health Sciences in 2001. Dr. Tily holds California license A98974.

Dr. Tily's primary practice is Sutter Valley Medical Foundation, at 600 Coffee Rd, Modesto, CA 95355 in Stanislaus County. The practice phone is (209) 524-1211.

Dr. Tily's primary practice is Sutter Valley Medical Foundation in Modesto, California. Dr. Tily is also affiliated with Memorial Medical Center. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Tily to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tily practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Tily's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Tily is board certified in rheumatology by the American Board of Internal Medicine. Dr. Tily is licensed in California.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, gout, joint arthropathy, joint cyst, joint pain and lupus among the conditions Dr. Tily treats.

CMS data shows 10,574 Medicare services from Dr. Tily across 13 procedure codes in 2024, for 883 Medicare patients. Medicare paid $179,788 for them.

CMS counts 883 Medicare patients who saw Dr. Tily in 2024. The largest group is 65 to 74, with 418 patients. 75% of them have arthritis, and 75% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tily's median patient age at 68, with 75% women.

In 2024, Dr. Tily wrote 9,532 Medicare Part D claims for 1,039 patients. 84% of them were for generic drugs. CMS names the drug for 9,317 of them, across 70 drugs with 11 or more claims each, at $7,535,005 in total drug cost. In 2023, CMS named 9,112 claims across 65 drugs.

Dr. Tily accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tily as offering telehealth. CMS counts 36 procedures of skin biopsy by Dr. Tily, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Tily, published from 2012 to 2018. 2013 was the busiest year, with 2. The most frequent topics are Lupus Erythematosus, Systemic, T-Lymphocytes and TOR Serine-Threonine Kinases. Dr. Tily's most frequent co-authors are Maha M. Dawood, MD, Andras Perl, MD and Paul E. Phillips, MD.

CMS Open Payments shows 831 general payments to Dr. Tily from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $2,584.

Dmand AI lists 2 awards for Dr. Tily, most recently CMS Stage 1 EHR in 2013.

Dr. Tily graduated from Dow University of Health Sciences in 2001. Dr. Tily is a member of ACR.

Dr. Tily is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.